Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 100% technical buy signal
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 9 new highs and up 15.93% in the last month
- Relative Strength index 63.98%
- Technical support level at 80.01
- Recently traded at 86.62 with a 50 day moving average of 79.20
Fundamental factors:
- Market Cap $ 18.68 billion
- P/E 35.39
- Revenue expected to grow 1060% this year and another 10.80% next year
- Earnings estimated to increase 15.30% this year, an additional 15.20% next year and continue to compound at an annual rate of 15.03% for the next 5 years
- Wall Street analysts issued 6 strong buy, 12 buy, 6 hold and a sell recommendation on the stock
The usual technical trading strategies haven't been that reliable on this stock so I would use a trailing stop loss to preserve your gains.